Ankle-Brachial Index (MESI)
Non-invasive screening for peripheral artery disease and cardiovascular risk
Table of contents
Basic data
The Ankle-Brachial Index (ABI) is a simple, non-invasive test that compares blood pressure in the ankle with that in the arm. It helps detect peripheral artery disease (PAD), a condition where narrowed arteries reduce blood flow to the limbs.
Early detection of PAD is important because it may indicate widespread atherosclerosis, which increases the risk of heart attack and stroke. This test is particularly valuable for individuals over 50, smokers, diabetics, and those with high cardiovascular risk.
Category: Lab functional test
Level: Intermediate
Usefulness: Medium
Level
Intermediate
Usefulness
Medium
Early detection of peripheral artery disease (PAD)
Identifies narrowing of the arteries in the legs, which can go undetected for years. PAD increases the risk of heart attack, stroke, and mobility limitations.
Cardiovascular risk assessment
ABI results correlate with overall atherosclerotic burden and can be used alongside cholesterol and blood pressure data to refine CVD risk profiling.
How it works
Blood pressure cuffs placed on limbs
Cuffs are applied to the upper arms and ankles. Sensors detect systolic blood pressure at each site.
Ratio is calculated
The ankle pressure is divided by the arm pressure to determine the ABI. Values <0.9 may indicate PAD, while >1.3 could suggest arterial stiffness.
Measures
ABI score (right and left leg)
Indicates the presence and severity of peripheral artery disease. Normal range is 1.0–1.4.
Pulse waveforms
Some devices (like MESI) provide waveform quality, which supports assessment of arterial elasticity and signal clarity.
Reliability
Repeatability
With proper technique and equipment, ABI results are reliable and reproducible in most users.
Sensitivity to user state
Cold limbs, recent exercise, or arrhythmias may affect readings. It is best performed in resting conditions.
Limitations
May miss early-stage PAD
In some cases, the ABI may appear normal even when mild arterial disease is present.
Limited use in people with calcified arteries
Conditions like diabetes or chronic kidney disease can cause falsely elevated ABI due to arterial stiffness.
Frequency
Suggested cadence
For individuals with risk factors, once every 1–2 years may be sufficient. Others may only require screening every few years or when symptoms arise.
Cost
Typical costs
Around $30–$100 USD depending on location and clinic. Some cardiovascular panels include it at no additional charge.
Availability
Where available
Available in many cardiology clinics, vascular labs, and select health screening centers. MESI and similar devices are increasingly common in primary care settings.
Preparation
How to prepare
No special preparation is needed. Avoid intense leg activity immediately before the test to ensure accurate readings.
Interpretation
Normal ABI (1.0–1.4)
Indicates healthy arterial flow. No further testing needed unless symptoms are present.
Borderline (0.91–0.99) or Abnormal (<0.90)
Suggests possible PAD. May warrant additional imaging or referral to a vascular specialist.
Alternatives
Pulse volume recording (PVR)
A more detailed vascular test using waveform analysis and segmental pressures to assess arterial disease.
Doppler ultrasound
Offers more visual detail of arterial flow and blockages, typically used in follow-up to ABI.
FAQ
Can ABI detect heart disease?
ABI does not directly assess the heart, but it is a strong predictor of cardiovascular risk.
Is the test painful?
No — it's completely non-invasive and typically takes under 15 minutes.